scholarly journals Prescription Patterns of Chinese Herbal Products for Osteoporosis in Taiwan: A Population-Based Study

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Wei-Tai Shih ◽  
Yao-Hsu Yang ◽  
Pau-Chung Chen

Background. Traditional Chinese medicine (TCM) includes Chinese herbal products (CHPs), acupuncture, and traumatology manipulative therapies. TCM physicians often prescribe CHP to treat patients with osteoporosis; however, the drugs used and their patterns of prescriptions have yet to be characterized. This study, therefore, aimed to evaluate the CHP used for the treatment of osteoporosis in Taiwan and their prescription patterns.Methods. A cohort of one million randomly sampled cases from the National Health Insurance Research Database (NHIRD) was analyzed to evaluate the frequencies and percentages of herbal formula and single herb prescriptions for osteoporosis. Association rules were then applied to evaluate the CHP coprescription patterns and the prevalence of osteoporosis.Results. The osteoporosis cohort included 16 544 patients, of whom more than 70% had used TCM on one or more occasion. Of these patients, 4 292 (25.9%) had been hospitalized at least once because of fracture. Du-Huo-Ji-Sheng-Tang and Du Zhong (Cortex Eucommiae) were the most frequently prescribed herbal formula and single herb, respectively, for the treatment of osteoporosis.Conclusion. This study identified patterns of CHP use for the treatment of osteoporosis. However, further research is required to fully elucidate the efficacy and safety of these CHP.

2015 ◽  
Vol 171 ◽  
pp. 223-230 ◽  
Author(s):  
Hung-Rong Yen ◽  
Ying-Yu Chen ◽  
Tzu-Ping Huang ◽  
Tung-Ti Chang ◽  
Jung-Ying Tsao ◽  
...  

2015 ◽  
Vol 173 ◽  
pp. 11-19 ◽  
Author(s):  
Hou-Hsun Liao ◽  
Chia-Chou Yeh ◽  
Che-Chen Lin ◽  
Bor-Chyuan Chen ◽  
Ming-Hsien Yeh ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Chia-Jung Lee ◽  
Steven Kuan-Hua Huan ◽  
Yi-Hui Lee ◽  
Yu-Shao Yeh ◽  
I-Hsin Lin ◽  
...  

The indications for the concentrated extract product (CEP) of Wu Lin San (WLS) are urethritis, cystitis, and gonorrhea. In clinical settings, WLS is combined with other CEPs used. However, there are no prescribed guidelines of CEPs in Taiwan. In this study, we would establish the CEP-prescribed applications of WLS for cystitis according to the clinical prescription patterns and ancient traditional medicine books. The prescription patterns of WLS were analyzed from the National Health Insurance Research Database of Taiwan for the period from 2000 to 2015. The results show that WLS was most frequently prescribed for cystitis (17.12% of a total prescriptions), and its prescribed dosage was 3∼5 g per day. Among them, 62.53% were for patients >40 years, and 72.45% were for women. Moreover, prescription patterns of WLS for cystitis were divided into 4 types: Type 1, WLS combined with Pa Cheng San (PCS) and Ti Tang Tang (29.75%); Type 2, WLS combined with PCS and dandelion (13.89%); Type 3, WLS combined with PCS and Tao Ho Cheng Chi Tang (6.63%); and Type 4, WLS combined with PCS (2.75%). According to lectures, review revealed the following principles of WLS application. WLS only should be adopted for simple heat strangury, while Type 4 should be applied for excess heat and dampness strangury. For patients with heat strangury coupled with an early-stage blood amassment pattern in lower jiao (abdomen), Type 3 could be administered. Type 2 should be used for heat strangury accompanied by dampness toxicity with infection. By contrast, Type 1 should be applied to patients with severe blood stasis. The application principles of WLS with other CEPs could serve as a reference for cystitis treatment in clinical settings.


2014 ◽  
Vol 155 (3) ◽  
pp. 1534-1540 ◽  
Author(s):  
Der-Shiang Tsai ◽  
Yuan-Shiun Chang ◽  
Tsai-Chung Li ◽  
Wen-Huang Peng

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Wei-Lung Hsu ◽  
Yueh-Ting Tsai ◽  
Chien-Tung Wu ◽  
Jung-Nien Lai

Background.The purpose of our study is to analyze the association between prescribed Chinese herbal products (CHPs) containingGinsengand the risk of endometrial cancer among tamoxifen (TMX) users and to identify any possible interactive effects betweenGinsengand TMX with respect to preventing the development of subsequent endometrial cancer in an estrogen-dependent breast cancer population in Taiwan.Methods.All patients newly diagnosed with invasive breast cancer receiving tamoxifen treatment from January 1, 1998, to December 31, 2008, were selected from the National Health Insurance Research Database. The usage, frequency of service, and CHP-Ginsengprescribed across the 30,556 TMX-treated breast cancer (BC) survivors were evaluated. Logistic regression was employed to estimate the odds ratios (ORs) for the utilization of CHP-Ginseng. Cox’s proportional hazard regression was performed to calculate the hazard ratios (HRs) for endometrial cancer associated withGinsenguse among the TMX-treated BC cohort.Results.The HR for the development of endometrial cancer among breast cancer survivors who had ever takenGinsengafter TXM treatment was significantly decreased compared to those who never used CHP.Conclusion.A significant inhibitory relationship betweenGinsengconsumption and subsequent endometrial cancer less than 2 years after TMX treatment was detected among BC survivors.


2017 ◽  
Vol 228 ◽  
pp. 90-96 ◽  
Author(s):  
Ming-Yen Tsai ◽  
Wen-Long Hu ◽  
Che-Chen Lin ◽  
Yi-Chiao Lee ◽  
Shih-Yu Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document